Javitt Daniel C. 4
4 · NRX Pharmaceuticals, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
Javitt Daniel C.
10% Owner
Transactions
- Sale
Common Stock
2022-07-29$1.01/sh−784,063$791,433→ 9,872,901 total(indirect: By LLC)
Footnotes (1)
- [F1]Held by Glytech LLC of which the Reporting Person is the sole owner.